Financial information, reports, calendar and more
Affibody Medical AB (publ) is Swedish a privately held limited liability company based in Stockholm.
The Company prepares Corporate Governance Reports in accordance with the Companies Act. In addition the Company complies with applicable parts of Code of Corporate Governance (the “Corporate Governance Code”).
The Corporate Governance Report including the auditor’s Review report is included in the Swedish Annual Report.
Affibodys latest Press releases
Affibody, ACELYRIN, and Inmagene Biopharmaceuticals Announce Data from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis Presented During 2022 European Alliance of Associations for Rheumatology Congress
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report January to March 2020 (May 15, 2020)
- Interim Report January to June 2020 (August 21, 2020)
- Interim Report January to September 2020 (November 13, 2020)
- Year End Report 2020 (February 2021)